Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.15-$3.25 for the period, compared to the consensus estimate of $3.44. The company issued revenue guidance of $1.603-$1.618 billion, compared to the consensus revenue estimate of $1.62 billion. Integra LifeSciences also updated […]
Eagle Asset Management Inc. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 285,809 shares of the life sciences company’s stock after purchasing an […]
Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have received an average recommendation of “Hold” from the nine ratings firms that are covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to […]
Cascade Investment Advisors Inc. acquired a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,185 shares of the life sciences company’s stock, valued at approximately $962,000. Several other institutional investors […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability. Volatility and Risk Integra LifeSciences has a beta […]